Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lori Freedman currently holds 469,272 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lori Freedman has been a net seller of ORGO stock. They have purchased $0 and sold $92.7K worth of shares.
Lori Freedman's most recent insider trade was on Apr 1, 2024, when they sold 1,974 shares at $2.80 per share.
Lori Freedman serves as Executive at Organogenesis Holdings Inc. (ORGO). They have executed 27 insider transactions totaling $92.7K over their tenure at the company.
Lori Freedman holds the position of Executive at Organogenesis Holdings Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Lori Freedman has shown a selling trading pattern, with $0 in total purchases and $92.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lori Freedman was on Feb 15, 2024, when they sold $79.2K worth of ORGO shares. This transaction involved 21,516 shares at $3.68 per share.
Lori Freedman currently owns 469,272 shares of Organogenesis Holdings Inc. (ORGO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lori Freedman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lori Freedman has 27 Form 4 filings on record as an insider at Organogenesis Holdings Inc..
Set alerts for Lori Freedman and 40,000+ other insiders.